Inventor · disambiguated record
Philip Brohawn
Also filed as: BROHAWN PHILIP · BROHAWN PHILIP Z
0 granted patents·9 pending applications·0 citations·filing 2011–2022
Top patents by PatentIndex Score
9 records- 0169US2023145764A1Blood-based tumor mutation burden predicts overall survival in nsclcMEDIMMUNE LLC·Filed 2022·Application pending·0 cites
- 0263US2020190598A1Blood-based tumor mutation burden predicts overall survival in nsclcMEDIMMUNE LLC·Filed 2019·Application pending·0 cites
- 0348US2015252431A1Compositions and methods for identifying b cell malignancies responsive to b cell depleting therapyMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
- 0448US2017088628A1Compositions and Methods for Identifying B Cell Malignancies Responsive to B Cell Depleting TherapyMEDIMMUNE LLC·Filed 2016·Application pending·0 cites
- 0545US2022396630A1Type i interferon inhibition in systemic lupus erythematosusASTRAZENECA AB·Filed 2020·Application pending·0 cites
- 0641US2018282417A1Tumor burden as measured by cell free dnaMEDIMMUNE LLC·Filed 2018·Application pending·0 cites
- 0739US2017275347A1Methods for identifying patients responsive to anti-pd-l1 antibody therapyMEDIMMUNE LTD·Filed 2015·Application pending·0 cites
- 0838US2018079814A1Combined anti-pld-1 and anti-ctla-4 antibodies for treating non-small lung cancerMEDIMMUNE LTD·Filed 2016·Application pending·0 cites
- 0932US2011256155A1Methods to molecularly characterize circulating tumor cellsMEDIMMUNE LLC·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Philip Brohawn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →